Restoration of sarcolemmal thiolic enzymes by the oral iron chelators dimethyl- and diethylhydroxypyrid-4-one in iron-loaded heart cells
Hershko, C.; Link, G.; Pinson, A.
Blood 82(10 Suppl 1): 95A
1993
ISSN/ISBN: 0006-4971 Accession: 033219629
PDF emailed within 1 workday: $29.90
Related References
Hershko, C.; Link, G.; Pinson, A. 1994: The oral iron chelators dimethyl- and diethyl-hydroxypyrid-4-one are able to restore sarcolemmal thiolic enzymes in rat heart cells British Journal of Haematology 87(Suppl 1): 61Link, G.; Pinson, A.; Hershko, C. 1994: Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells Blood 83(9): 2692-2697
Link, G.; Pinson, A.; Hershko, C. 1994: Identification of thiolic sarcolemmal proteins as a primary target of iron toxicity in cultured heart cells Advances in Experimental Medicine and Biology 356: 267-276
Collins, A.F.; Fassos, F.F.; Stobie, S.; Lewis, N.; Shaw, D.; Fry, M.; Templeton, D.M.; McClelland, R.A.; Koren, G.; Olivieri, N.F. 1994: Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease Blood 83(8): 2329-2333
Glickstein, H.; El, R.B.; Link, G.; Breuer, W.; Konijn, A.M.; Hershko, C.; Nick, H.; Cabantchik, Z.I. 2006: Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences Blood 108(9): 3195-3203
Kontoghiorghes, G.J.; Kolnagou, A.; Skiada, A.; Petrikkos, G. 2010: The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies Hemoglobin 34(3): 227-239
Olivieri, N.F.; Matsui, D.; Liu, P.P.; Blendis, L.; Cameron, R.; McClelland, R.A.; Templeton, D.M.; Koren, G. 1993: Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients Bone Marrow Transplantation 12(Suppl 1): 9-11
Olivieri, N.F.; Templeton, D.M.; Koren, G.; Chung, D.; Hermann, C.; Freedman, M.H.; McClelland, R.A. 1990: Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients Annals of the new York Academy of Sciences 612: 369-377
Kontoghiorghes, G.J.; Sheppard, L.; Hoffbrand, A.V.; Charalambous, J.; Tikerpae, J.; Pippard, M.J. 1987: Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats Journal of Clinical Pathology 40(4): 404-408
Hershko, C.; Konijn, A.M.; Nick, H.P.; Breuer, W.; Cabantchik, Z.I.; Link, G. 2001: ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture Blood 97(4): 1115-1122
Hohnholt, M.; Geppert, M.; Dringen, R. 2010: Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells Neurochemical Research 35(8): 1259-1268
Guyader, D.; Zanninelli, G.; Favier, A.; Gollan, J.L.; Brissot, P. 1992: Comparative efficacy of oral iron chelators on the biliary excretion of plasma non-transferrin-bound iron in normal and iron overloaded rats Hepatology 16(4 Part 2): 114A
Youdim, M.B.H.; Stephenson, G.; Ben Shachar, D. 2004: Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28 Annals of the new York Academy of Sciences 1012: 306-325
Link, G.; Konijn, A.M.; Breuer, W.; Cabantchik, Z.I.; Hershko, C. 2001: Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture Journal of Laboratory and Clinical Medicine 138(2): 130-138
Link, G.; Konijn, A.M.; Breuer, W.; Cabantchik, Z.I.; Hershko, C. 2001: Exploring the iron shuttle hypothesis in chelation therapy : Effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture The Journal of Laboratory and Clinical Medicine 138(2): 130-138